The Psychedelic Policy Quagmire : Health, Law, Freedom, and Society (Psychology, Religion, and Spirituality)

個数:

The Psychedelic Policy Quagmire : Health, Law, Freedom, and Society (Psychology, Religion, and Spirituality)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 440 p.
  • 言語 ENG
  • 商品コード 9781440839702
  • DDC分類 320.01

Full Description

Edited by two preeminent scholars, this book provides coverage of the policy issues related to the increasingly diverse treatments, practices, and applications of psychedelics.
Hallucinogenic substances like LSD, mescaline, peyote, MDMA, and ayahuasca have a reputation as harmful substances that are enjoyed only by recreational users committing criminal acts. But leading international researchers and scholars who contributed to this book hold that the use of psychedelic substances for health, religious, intellectual, and artistic purposes is a Constitutional right—and a human right. Based on that conclusion, these scholars focus on policy issues that regulate the use of psychedelic drugs in medicine, religion, personal life, and higher education, arguing that existing regulations should match current and anticipated future uses.

This volume has two parts. The first surveys research on the use of psychedelic drugs in medicine, religion, and truth-seeking, following these topics through history and contemporary practice. The second section treats government policices that regulate the psychological, physiological, biochemical, and spiritual aspects of research and experience in these fields. The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society challenges medical and legal policy experts, ethicists, scientists, and scholars with the question: How can we formulate policies that reduce the dangers of psychedelics' misuse and at the same time maximize the emerging diverse benefits?

Contents

Series Editor's Foreword by J. Harold Ellens
Introduction by J. Harold Ellens and Thomas B. Roberts
Section I: Psychedelics, Medicine, Religion, and Truth
Chapter 1 You Have a Constitutional Right to Psychedelics: Academic Freedom, Personal Conscience, and Psychotechnologies
Thomas B. Roberts
Chapter 2 A Brief History of Psychedelics in Medical Practices: Psychedelic Medical History "before the Hiatus"
Ben Sessa
Chapter 3 Continuing History of Psychedelics in Medical Practices: The Renaissance of Psychedelic Medical Research
Ben Sessa
Chapter 4 Psychedelic Medicines
Michael J. Winkelman
Chapter 5 Psychedelic Psychotherapy Near the End of Life
Charles S. Grob and Alicia Danforth
Chapter 6 Do Drugs Have Religious Import? A 35-Year Retrospect
Huston Smith
Chapter 7 Understanding the Religious Import of Mystical States of Consciousness Facilitated by Psilocybin
William A. Richards
Chapter 8 Pilgrimage to the Light? On the Threshold of a Dream: Sacred Plants, Passionate Dedication to Ideals, and Healing
Richard Yensen
Chapter 9 Ayahuasca and the Vines of Politics
Danny Nemu
Chapter 10 Psychedelics as a Practice of Truth: A Foucauldian Argument
Pieter Stokkink
Chapter 11 The Transpersonal, Psychedelics, and Mainstream Psychology: Why the Wide Divide?
James R. Fadiman
Section II: Psychedelics, Psychology, Rights, and Policy
Chapter 12 Psychoactive Stimulation and Psychoactive Substances: Conceptual and Ethical Considerations
David Bryce Yaden, Derek Egan Anderson, Marcelo Gomes Mattar, and Andrew B. Newberg
Chapter 13 Mindapps and the Neurosingularity Project
Thomas B. Roberts
Chapter 14 Entheogenic Experience as a Human Right
Martin W. Ball
Chapter 15 Psychedelics and Criminality: A Possible Pathway to Reduced Recidivism?
Peter S. Hendricks
Chapter 16 Plant Psychedelics in the English Courts: Legal Uncertainty, Guinea Pigs, and "Dog Law"
Charlotte Walsh
Chapter 17 Therapeutic Hallucinogens: Altered State Laws for Altered States
Mitch Earleywine and Mallory Loflin
Chapter 18 Changing Psychedelics Policy
Neal M. Goldsmith
Chapter 19 The DEA: Four Decades of Impeding and Rejecting Science
Drug Policy Alliance and the Multidisciplinary Association for Psychedelic Studies
Chapter 20 Regulation of the Prescription Use of Psychedelics
Rick Doblin
Conclusion Dear God, No More Committees!
Thomas B. Roberts and J. Harold Ellens
About the Editors
About the Contributors
Index

最近チェックした商品